期刊文献+
共找到91篇文章
< 1 2 5 >
每页显示 20 50 100
补阳还五汤及其组分治疗阿尔茨海默病的研究进展 被引量:13
1
作者 黄洋 孙英新 +4 位作者 曾妙 黄培锋 甘家丽 杨琳 姜希娟 《中国实验方剂学杂志》 CAS CSCD 北大核心 2019年第19期212-218,共7页
阿尔茨海默病(AD)是一种起病隐匿的神经系统退行性疾病,其病因病机复杂,主要以胆碱能神经元损伤及神经突触缺失为病理改变,长期以来单一致病因素作为治疗靶点的研究收效欠佳。中医复方因其具有多通路多靶点干预的优势,在防治AD方面有显... 阿尔茨海默病(AD)是一种起病隐匿的神经系统退行性疾病,其病因病机复杂,主要以胆碱能神经元损伤及神经突触缺失为病理改变,长期以来单一致病因素作为治疗靶点的研究收效欠佳。中医复方因其具有多通路多靶点干预的优势,在防治AD方面有显著效果。益气活血代表方-补阳还五汤广泛应用于脑血管疾病,对保护神经元、修复血脑屏障降低通透性对抗脑水肿、抵御血管内皮细胞损伤、促进新血管生成和成熟等方面具有显著的疗效。因其对大脑多方面强大的治疗作用,大量学者研究发现补阳还五汤对改善认知功能损伤疗效显著,且不同的组分通过不同的机制发挥改善认知损伤的治疗效果。但不同研究所侧重的作用机制相对单一,不利于全面认知其作用机制和干预靶点。文章总结近年相关文献从补阳还五汤及其组分降低β淀粉样前体蛋白(APP)表达减少β样淀粉蛋白沉积、抑制中枢神经系统炎症信号通路减少炎症因子释放、抑制神经元凋亡因子表达保护神经元、修复血脑屏障减少有害物质进入中枢神经系统、提高低密度脂蛋白相关受体(LRP)-1含量,降低晚期糖基化受体(RAGE)表达增加β淀粉样蛋白外周清除等方面阐述其保护神经元、改善学习及认知功能障碍的机制,以期为补阳还五汤治疗阿尔茨海默病提供有力的文献支持。 展开更多
关键词 补阳还五汤 阿尔茨海默病 中医药 Β淀粉样蛋白 神经炎症
原文传递
Neural progenitor cells but not astrocytes respond distally to thoracic spinal cord injury in rat models 被引量:9
2
作者 Tara Nguyen Yilin Mao +1 位作者 Theresa Sutherland Catherine Anne Gorrie 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第11期1885-1894,共10页
Traumatic spinal cord injury (SCI) is a detrimental condition that causes loss of sensory and motor function in an individual. Many complex secondary injury cascades occur after SCI and they offer great potential fo... Traumatic spinal cord injury (SCI) is a detrimental condition that causes loss of sensory and motor function in an individual. Many complex secondary injury cascades occur after SCI and they offer great potential for therapeutic targeting. In this study, we investigated the response of endogenous neural progenitor cells, astrocytes, and microglia to a localized thoracic SCI throughout the neuroaxis. Twenty-five adult female Sprague-Dawley rats underwent mild-contusion thoracic SCI (n = 9), sham surgery (n = 8), or no surgery (n = 8). Spinal cord and brain tissues were fixed and cut at six regions of the neuroaxis. Immunohistochem- istry showed increased reactivity of neural progenitor cell marker nestin in the central canal at all levels of the spinal cord. Increased reactivity of astrocyte-specific marker glial fibrillary acidic protein was found only at the lesion epicenter. The number of activated microglia was significantly increased at the lesion site, and activated microglia extended to the lumbar enlargement. Phagocytic microglia and macrophages were significantly increased only at the lesion site. There were no changes in nestin, glial fibrillary acidic protein, microglia and macrophage response in the third ventricle of rats subjected to mild-contusion thoracic SCI compared to the sham surgery or no surgery. These findings indicate that neural progenitor cells, astrocytes and microglia respond differently to a localized SCI, presumably due to differences in inflammatory signaling. These different cellular responses may have implications in the way that neural progenitor cells can be manipulated for neuroregeneration after SCI. This needs to be further investigated. 展开更多
关键词 nerve regeneration CONTUSION spinal cord neuroinflammatory ependymal cell glial fibrillary acidic protein MICROGLIA NESTIN neuroaxis TANYCYTE third ventricle trauma neural regeneration
下载PDF
香椿子多酚通过p38 MAPK通路抑制6-OHDA诱导的神经炎症反应 被引量:11
3
作者 刘飞 费学超 +3 位作者 李侃 庄文欣 吕娥 付文玉 《神经解剖学杂志》 CSCD 北大核心 2017年第6期665-671,共7页
目的:研究香椿子多酚(PTSS)通过调节p38促分裂原活化蛋白激酶(p38 MAPK)信号通路抑制神经毒素6-羟多巴胺(6-OHDA)所诱导的PC12细胞帕金森病(PD)模型的神经炎症反应。方法:将PC12细胞分为四组:对照组、模型组(6-OHDA 100μmol/L)、PTSS... 目的:研究香椿子多酚(PTSS)通过调节p38促分裂原活化蛋白激酶(p38 MAPK)信号通路抑制神经毒素6-羟多巴胺(6-OHDA)所诱导的PC12细胞帕金森病(PD)模型的神经炎症反应。方法:将PC12细胞分为四组:对照组、模型组(6-OHDA 100μmol/L)、PTSS低剂量组(6-OHDA+PTSS 100μmol/L)、PTSS高剂量组(6-OHDA+PTSS 200μmol/L)。倒置显微镜下观察各组PC12细胞形态学的变化;采用细胞计数CCK-8法检测细胞活性;免疫细胞化学染色法和Western Blot检测诱导性一氧化氮合酶(iNOS)、环氧化酶-2(COX-2)、核因子κB p65(NF-κB p65)、p38 MAPK和p-p38 MAPK的表达变化。结果:(1)细胞形态观察显示:与对照组相比,6-OHDA模型组细胞胞体出现空泡,皱缩变形颜色暗淡,部分细胞折光性增高,细胞死亡数目明显增多,细胞聚集成片。PTSS低剂量组,细胞状态明显改善。(2)模型组PC12细胞活力显著降低,而PTSS能有效抑制PC12细胞活力的降低(P<0.05),PTSS低剂量组比高剂量组改善效果更为显著(P<0.05)。(3)与对照组比较,模型组细胞iNOS、COX-2、NF-κB p65、p38 MAPK和p-p38 MAPK表达明显升高,而PTSS组上述分子表达明显降低。结论:PTSS可有效逆转6-OHDA导致的PC12细胞损伤,其机制可能与下调p38 MAPK信号通路从而抑制神经炎症反应有关。 展开更多
关键词 香椿子多酚 6-羟多巴胺 帕金森病 P38 MAPK 神经炎症
下载PDF
The lymphatic system:a therapeutic target for central nervous system disorders 被引量:6
4
作者 Jia-Qi Xu Qian-Qi Liu +4 位作者 Sheng-Yuan Huang Chun-Yue Duan Hong-Bin Lu Yong Cao Jian-Zhong Hu 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第6期1249-1256,共8页
The lymphatic vasculature forms an organized network that covers the whole body and is involved in fluid homeostasis,metabolite clearance,and immune surveillance.The recent identification of functional lymphatic vesse... The lymphatic vasculature forms an organized network that covers the whole body and is involved in fluid homeostasis,metabolite clearance,and immune surveillance.The recent identification of functional lymphatic vessels in the meninges of the brain and the spinal cord has provided novel insights into neurophysiology.They emerge as major pathways for fluid exchange.The abundance of immune cells in lymphatic vessels and meninges also suggests that lymphatic vessels are actively involved in neuroimmunity.The lymphatic system,through its role in the clearance of neurotoxic proteins,autoimmune cell infiltration,and the transmission of pro-inflammatory signals,participates in the pathogenesis of a variety of neurological disorders,including neurodegenerative and neuroinflammatory diseases and traumatic injury.Vascular endothelial growth factor C is the master regulator of lymphangiogenesis,a process that is critical for the maintenance of central nervous system homeostasis.In this review,we summarize current knowledge and recent advances relating to the anatomical features and immunological functions of the lymphatic system of the central nervous system and highlight its potential as a therapeutic target for neurological disorders and central nervous system repair. 展开更多
关键词 central nervous system central nervous system injury glymphatic system lymphatic vessels MENINGES neurodegenerative disorders neuroinflammatory diseases vascular endothelial growth factor C
下载PDF
Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process 被引量:9
5
作者 Mariana Toricelli Arthur Antonio Ruiz Pereira +4 位作者 Guilherme Souza Abrao Helena Nascimento Malerba Julia Maia Hudson Sousa Buck Tania Araujo Viel 《Neural Regeneration Research》 SCIE CAS CSCD 2021年第1期58-67,共10页
Aging is a dynamic and progressive process that begins at conception and continues until death.This process leads to a decrease in homeostasis and morphological,biochemical and psychological changes,increasing the ind... Aging is a dynamic and progressive process that begins at conception and continues until death.This process leads to a decrease in homeostasis and morphological,biochemical and psychological changes,increasing the individual’s vulnerability to various diseases.The growth in the number of aging populations has increased the prevalence of chronic degenerative diseases,impairment of the central nervous system and dementias,such as Alzheimer’s disease,whose main risk factor is age,leading to an increase of the number of individuals who need daily support for life activities.Some theories about aging suggest it is caused by an increase of cellular senescence and reactive oxygen species,which leads to inflammation,oxidation,cell membrane damage and consequently neuronal death.Also,mitochondrial mutations,which are generated throughout the aging process,can lead to changes in energy production,deficiencies in electron transport and apoptosis induction that can result in decreased function.Additionally,increasing cellular senescence and the release of proinflammatory cytokines can cause irreversible damage to neuronal cells.Recent reports point to the importance of changing lifestyle by increasing physical exercise,improving nutrition and environmental enrichment to activate neuroprotective defense mechanisms.Therefore,this review aims to address the latest information about the different mechanisms related to neuroplasticity and neuronal death and to provide strategies that can improve neuroprotection and decrease the neurodegeneration caused by aging and environmental stressors. 展开更多
关键词 cell senescence cell signaling CHOLINERGIC enriched environment long-term potentiation NEURODEGENERATION NEUROGENESIS neuroinflammatory neuronal death NEUROPROTECTION neurotophin
下载PDF
Exploring the Association between Oral Microbiome and Mild Cognitive Impairment: A Narrative Review
6
作者 Arghavan Tonkaboni Maryam Sayyari +3 位作者 Pedram Khodadadzadeh Sotude Khorshidi Shaghayegh Golalipour Leyli Haghighi 《Advances in Alzheimer's Disease》 CAS 2024年第2期27-34,共8页
Objective: Some studies have investigated the association between oral microbiome and mild cognitive impairment (MCI). However, there needs to be more narrative reviews synthesizing this evidence. This study aimed to ... Objective: Some studies have investigated the association between oral microbiome and mild cognitive impairment (MCI). However, there needs to be more narrative reviews synthesizing this evidence. This study aimed to bridge this gap in the current knowledge. Methods: A comprehensive search was conducted on PubMed (MEDLINE) to identify studies examining the association between the oral microbiome and MCI. Search parameters and inclusion criteria were clearly defined, encompassing terms related to the oral microbiome, MCI, and their association. Two authors independently selected relevant studies and performed data extraction. Result: Four studies were included. Two cohort studies and two case-control reported an association between the oral microbiome and MCI. Conclusion: Based on the evidence synthesized from the included studies, the review suggests an association between MCI and the oral microbiome. Specifically, all included studies identified significant differences in the abundance of specific microbial species between individuals with MCI and those with normal cognitive function, underscoring the potential role of these species in neuroinflammatory diseases. 展开更多
关键词 MICROBIOTA Neurocognitive Disorders Neuroinflammations Alzheimer’s Disease Cognitive Dysfunction neuroinflammatory Disorder
下载PDF
Bioinspired metal-organic framework nanozyme reinforced with thermosensitive hydrogel for regulating inflammatory responses in Parkinson’s disease 被引量:1
7
作者 Xiaowan Fan Tao Zhang +4 位作者 Xin Ding Yushuo Gu Qing Li Wei Jiang Kelong Fan 《Nano Research》 SCIE EI CSCD 2024年第2期858-865,共8页
Parkinson’s disease(PD)is a prevalent neurodegenerative disorder accompanied by movement disorders and neuroinflammatory injury.Anti-inflammatory intervention to regulate oxidative stress in the brain is beneficial f... Parkinson’s disease(PD)is a prevalent neurodegenerative disorder accompanied by movement disorders and neuroinflammatory injury.Anti-inflammatory intervention to regulate oxidative stress in the brain is beneficial for managing PD.However,traditional natural antioxidants have failed to meet the clinical treatment demands due to insufficient activity and sustainability.Herein,Cu-doping zeolite imidazolate framework-8(ZIF-8)nanozyme is designed to simulate Cu/Zn superoxide dismutase(SOD)by biomimetic mineralization.The nanozyme composite is then integrated into thermosensitive hydrogel(poly(lactic-co-glycolic acid)-poly(ethylene glycol)-poly(lactic-co-glycolic acid)(PLGA-PEG-PLGA))to form an effective antioxidant system(Cu-ZIF@Hydrogel).The thermosensitive hydrogel incorporating nanozymes demonstrate distinct viscoelastic properties aimed at enhancing local nanozyme adhesion,prolonging nanozyme retention time,and modulating antioxidant activity,thus significantly improving the bioavailability of nanozymes.At the cellular and animal levels of PD,we find that Cu-ZIF@Hydrogel bypass the blood-brain barrier and efficiently accumulate in the nerve cells.Moreover,the Cu-ZIF@Hydrogel significantly alleviate the PD’s behavioral and pathological symptoms by reducing the neuroinflammatory levels in the lesion site.Therefore,the hydrogel-incorporating nanozyme system holds great potential as a simple and reliable avenue for managing PD. 展开更多
关键词 bioinspired nanozyme thermosensitive hydrogel Parkinson’s disease oxidative stress neuroinflammatory
原文传递
手术创伤及多次丙泊酚麻醉对发育期大鼠神经发育和认知功能的影响 被引量:6
8
作者 李扬 李伟光 +4 位作者 冯泽国 宋杰 张成岗 黄连军 宋燕平 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2021年第3期290-297,共8页
目的:探讨手术创伤及多次丙泊酚麻醉对发育期大鼠神经发育和认知功能的影响及相关机制。方法:104只13日龄SD大鼠随机分为4组:空白对照组、丙泊酚组、手术组、丙泊酚+手术组,每组26只。空白对照组连续5 d腹腔注射等渗氯化钠溶液7.5 m L&#... 目的:探讨手术创伤及多次丙泊酚麻醉对发育期大鼠神经发育和认知功能的影响及相关机制。方法:104只13日龄SD大鼠随机分为4组:空白对照组、丙泊酚组、手术组、丙泊酚+手术组,每组26只。空白对照组连续5 d腹腔注射等渗氯化钠溶液7.5 m L·kg^(-1)·d^(-1),丙泊酚组连续5 d腹腔注射丙泊酚75 mg·kg^(-1)·d^(-1),手术组行罗哌卡因局麻下剖腹探查术,后续4 d腹腔注射等渗氯化钠溶液7.5 m L·kg^(-1)·d^(-1),丙泊酚+手术组大鼠接受腹腔丙泊酚注射75 mg/kg后,罗哌卡因局麻下行剖腹探查术,随后4 d连续腹腔注射丙泊酚75 mg·kg^(-1)·d^(-1)。术后各组随机分为两个亚组。其中一个亚组造模完成后1 d检测海马组织中肿瘤坏死因子α(TNF-α)的浓度以及caspase-3、c-fos的表达,TUNEL检测观察新生鼠海马组织中神经元凋亡情况。另一亚组饲养至第60天时行莫里斯水迷宫实验评估大鼠认知功能,然后检测大鼠海马组织中TNF-α的浓度及caspase-3、c-fos的表达水平,TUNEL检测观察大鼠海马组织中神经元凋亡情况。结果:造模完成后1 d结果显示,与空白对照组比较,其他三组海马组织中TNF-α含量显著升高,caspase-3、c-fos表达增加,海马组织神经元凋亡数量增多(均P<0.05);与手术组比较,丙泊酚组和丙泊酚+手术组海马组织TNF-α含量增加,caspase-3、c-fos表达增加,海马神经元凋亡数量增加(均P<0.05),但丙泊酚组及丙泊酚+手术组两组间差异无统计学意义(均P>0.05)。莫里斯水迷宫实验结果表明,各组间游泳速度、登台潜伏期、目标象限停留时间和穿台次数差异无统计学意义(均P>0.05)。水迷宫实验后测定海马组织TNF-α浓度、caspase-3、c-fos的表达及海马神经元凋亡数量结果发现各组大鼠间差异无统计学意义(均P>0.05)。结论:新生大鼠接受局麻腹部手术和多次丙泊酚麻醉可引起中枢炎症介质释放增多,海马神经元凋亡增加,但该损� 展开更多
关键词 丙泊酚 手术创伤 神经元凋亡 中枢炎症 发育期大脑 认知功能 SD大鼠
下载PDF
口服L-苏糖酸镁预防长春新碱诱导的大鼠记忆和情感障碍
9
作者 陈佳新 周鑫 +2 位作者 熊媖 刘先国 舒海华 《中国疼痛医学杂志》 CAS CSCD 北大核心 2024年第6期413-423,共11页
目的:观察L-苏糖酸镁(magnesium-L-threonate,L-TAMS)对长春新碱(vincristine,VCR)诱导的大鼠记忆和情感障碍的影响并探讨其机制。方法:采用随机数表法将SD大鼠随机分为三组:Control组(饮用正常水并注射等量生理盐水)、VCR组(大鼠腹腔... 目的:观察L-苏糖酸镁(magnesium-L-threonate,L-TAMS)对长春新碱(vincristine,VCR)诱导的大鼠记忆和情感障碍的影响并探讨其机制。方法:采用随机数表法将SD大鼠随机分为三组:Control组(饮用正常水并注射等量生理盐水)、VCR组(大鼠腹腔注射长春新碱并饮用正常水)、L-TAMS+VCR组(VCR注射前7天起至实验结束在饮用水中加入L-TAMS),每组5~7只。采用新颖物体识别测试(novel object recognition test,NORT)检测大鼠记忆能力;高架十字迷宫实验(elevated plus-maze test,EPMT)检测大鼠焦虑行为;强迫游泳实验(forced swimming test,FST)检测大鼠抑郁行为。使用在体电生理实验技术记录海马CA3-CA1突触后诱发场电位的幅度;Western blot检测海马内N-甲基-D-天冬氨酸受体(N-Methyl-D-Aspartate-Receptors,NMDARs)亚基NR2B表达的情况;免疫荧光检测海马CA1与前扣带回皮质(anterior cingulate cortex,ACC)内小胶质细胞的表达情况。结果:与Control组比较,VCR组认知系数降低,静止不动时间延长,进入高架十字迷宫开放臂的时间和次数减少,海马CA3-CA1突触后场电位幅度降低,海马内NR2B含量显著降低,海马CA1和ACC内小胶质细胞的表达增多,腹腔注射VCR之前,提前7天直至实验结束口服L-TAMS可预防VCR所引起的上述变化。结论:L-TAMS可通过上调海马突触后膜NMDARs亚基NR2B,逆转VCR引起的CA3-CA1突触后场电位幅度显著降低,改善海马突触传递受损,同时,降低大鼠海马CA1和前扣带回皮质的小胶质细胞表达,减轻神经炎症,进一步预防VCR诱导的记忆和情感功能障碍。 展开更多
关键词 L-苏糖酸镁 长春新碱 记忆情感障碍 海马 前扣带回皮质 突触可塑性 神经炎症
下载PDF
穿心莲内酯抑制IKK/IκBα/NF-κB信号通路改善抑郁症大鼠的抑郁样行为 被引量:2
10
作者 赵雯婧 王婷婷 +4 位作者 邱雪 蔡晓 简薇 何宗岭 郑玉萍 《河北医药》 CAS 2023年第14期2085-2089,共5页
目的探讨穿心莲内酯(Andro)通过抑制核转录因子-κB抑制蛋白激酶(IKK)/核因子κB抑制蛋白(IκBα)/核因子-κB(NF-κB)信号通路改善抑郁症(MDD)大鼠的抑郁样行为。方法随机取12只SD大鼠作为空白对照组(NC组),其余大鼠采用慢性不可预知... 目的探讨穿心莲内酯(Andro)通过抑制核转录因子-κB抑制蛋白激酶(IKK)/核因子κB抑制蛋白(IκBα)/核因子-κB(NF-κB)信号通路改善抑郁症(MDD)大鼠的抑郁样行为。方法随机取12只SD大鼠作为空白对照组(NC组),其余大鼠采用慢性不可预知轻度应激(CUMS)结合孤养模式造模,将造模成功大鼠随机平分为模型组(Mod组)、Andro组(25 mg·kg^(-1)·d^(-1))、Res组(30 mg·kg^(-1)·d^(-1)IKK/IκBα/NF-κB信号通路激活剂Res)、Andro+Res组(25 mg·kg^(-1)·d^(-1)Andro+30mg·kg^(-1)·d^(-1)Res),每组12只大鼠,Mod组和NC组灌胃等量0.9%氯化钠溶液。旷场实验、糖水偏好实验、强迫游泳实验、平衡木实验评估大鼠行为;ELISA法检测血清IL-1β、IL-6、TNF-α水平;免疫荧光染色检测小胶质细胞、星形胶质细胞活性;Western blot检测NLRP3、cleaved-Caspase-1以及IKK/IκBα/NF-κB信号通路蛋白水平。结果与NC组相比,Mod组站立次数、饮用蔗糖量显著减少(P<0.05),游泳不动时间、通过平衡木时间、IL-1β、IL-6、TNF-α含量、Iba-1、GFAP阳性细胞数量、NLRP3、cleaved-Caspase-1、p-IKK/IKK、IκBα、p-NF-κB p65/NF-κB p65蛋白水平显著增加(P<0.05);与Mod组相比,Andro组大鼠游泳不动时间、通过平衡木时间、IL-1β、IL-6、TNF-α含量、Iba-1、GFAP阳性细胞数量、NLRP3、cleaved-Caspase-1、p-IKK/IKK、IκBα、p-NF-κB p65/NF-κB p65蛋白水平显著降低(P<0.05),站立次数、饮用蔗糖量显著增加(P<0.05),而Res组以上指标趋势相反(P<0.05);Res逆转了Andro对MDD大鼠抑郁样行为的改善。结论Andro可能通过下调IKK/IκBα/NF-κB通路对MDD大鼠的抑郁样行为起到一定的改善作用。 展开更多
关键词 穿心莲内酯 抑郁症 IKK/IκBα/NF-κB信号通路 抑郁样行为 神经炎症
下载PDF
Complementary and alternative medicine on cognitive defects and neuroinflammation after sepsis
11
作者 LI Zhenxuan WANG Xuerui +4 位作者 Luis Ulloa Ayman Youssef BAI Yunjing XU Xiaolong LIU Qingquan 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2024年第2期408-416,共9页
Sepsis-associated encephalopathy(SAE)is a common manifestation of sepsis,ranging from mild confusion and delirium to severe cognitive impairment and deep coma.SAE is associated with higher mortality and long-term outc... Sepsis-associated encephalopathy(SAE)is a common manifestation of sepsis,ranging from mild confusion and delirium to severe cognitive impairment and deep coma.SAE is associated with higher mortality and long-term outcomes,particularly substantial declines in cognitive function.The mechanisms of SAE probably include neuroinflammation that is mediated by systemic inflammation and ischemic lesions in the brain,a disrupted blood–brain barrier,oxidative stress,neurotransmitter dysfunction,and severe microglial activation.Increasing evidence suggests that complementary and alternative medicine,especially Traditional Chinese Medicine(TCM),is favorable in alleviating cognitive decline after sepsis.Here,we summarized the studies of traditional herbal remedies,TCM formulas and acupuncture therapy in animal models of neurological dysfunctions after sepsis in recent decades and reviewed their potential mechanisms. 展开更多
关键词 sepsis-associated encephalopathy cognitive dysfunction complementary therapies neuroinflammatory diseases medicine Chinese traditional review
原文传递
癫痫发作患儿血清HMGB1水平与疾病严重程度及预后的关系
12
作者 倪俊毅 沈瑾 +1 位作者 丁焘 施燕蓉 《国际检验医学杂志》 CAS 2024年第5期523-528,533,共7页
目的探讨癫痫发作患儿血清高迁移率族蛋白B1(HMGB1)水平与疾病严重程度及预后的关系。方法将2019年2月至2022年6月该院收治的癫痫患儿284例纳入研究作为癫痫组。将该院同期收治的伴癫痫发作的获得性脱髓鞘综合征(ADS)患儿18例作为ADS组... 目的探讨癫痫发作患儿血清高迁移率族蛋白B1(HMGB1)水平与疾病严重程度及预后的关系。方法将2019年2月至2022年6月该院收治的癫痫患儿284例纳入研究作为癫痫组。将该院同期收治的伴癫痫发作的获得性脱髓鞘综合征(ADS)患儿18例作为ADS组。另外,将同期于该院体检的146例健康儿童纳入研究作为对照组。患儿在急性癫痫发作或神经症状复发后48 h内使用酶联免疫吸附试验法检测血清HMGB1水平。对3组血清HMGB1水平进行比较。分析血清HMGB1水平与疾病严重程度的关系。以癫痫组患儿血清HMGB1水平中位值为界进行亚组分析,分析癫痫患儿血清HMGB1水平与癫痫发作类型、神经发育共病、癫痫持续状态等其他临床资料的关系。采用单因素和多因素Logistic回归分析影响癫痫患儿预后的因素。结果癫痫组和ADS组患儿血清HMGB1水平均高于对照组,差异有统计学意义(P<0.05),然而ADS组血清HMGB1水平与癫痫组比较,差异无统计学意义(P>0.05)。无论是癫痫组还是ADS组,血清HMGB1水平均与病程呈正相关(P<0.05)。此外,在癫痫组中,血清HMGB1水平与抗癫痫药物种类和采血前最后一次癫痫发作持续时间也呈正相关(P<0.05),而且随着脑电图异常程度变严重,血清HMGB1水平也升高(P<0.05)。血清HMGB1高水平亚组全面性发作(P=0.023)、伴有神经发育共病(P=0.008)、癫痫持续状态(P=0.002)患儿比例显著高于低水平亚组。经Logistic回归分析,血清HMGB1水平升高是癫痫患儿预后不良的独立危险因素(P<0.05)。结论血清HMGB1能反映癫痫患儿疾病严重程度,是癫痫患儿预后不良的独立危险因素。 展开更多
关键词 癫痫发作 高迁移率族蛋白B1 疾病严重程度 神经炎症 预后
下载PDF
Potential role of tanycyte-derived neurogenesis in Alzheimer's disease
13
作者 Guibo Qi Han Tang +2 位作者 Jianian Hu Siying Kang Song Qin 《Neural Regeneration Research》 SCIE CAS 2025年第6期1599-1612,共14页
Tanycytes, specialized ependymal cells located in the hypothalamus, play a crucial role in the generation of new neurons that contribute to the neural circuits responsible for regulating the systemic energy balance. T... Tanycytes, specialized ependymal cells located in the hypothalamus, play a crucial role in the generation of new neurons that contribute to the neural circuits responsible for regulating the systemic energy balance. The precise coordination of the gene networks controlling neurogenesis in naive and mature tanycytes is essential for maintaining homeostasis in adulthood. However, our understanding of the molecular mechanisms and signaling pathways that govern the proliferation and differentiation of tanycytes into neurons remains limited. This article aims to review the recent advancements in research into the mechanisms and functions of tanycyte-derived neurogenesis. Studies employing lineage-tracing techniques have revealed that the neurogenesis specifically originating from tanycytes in the hypothalamus has a compensatory role in neuronal loss and helps maintain energy homeostasis during metabolic diseases. Intriguingly,metabolic disorders are considered early biomarkers of Alzheimer's disease. Furthermore,the neurogenic potential of tanycytes and the state of newborn neurons derived from tanycytes heavily depend on the maintenance of mild microenvironments, which may be disrupted in Alzheimer's disease due to the impaired blood–brain barrier function.However, the specific alterations and regulatory mechanisms governing tanycyte-derived neurogenesis in Alzheimer's disease remain unclear. Accumulating evidence suggests that tanycyte-derived neurogenesis might be impaired in Alzheimer's disease, exacerbating neurodegeneration. Confirming this hypothesis, however, poses a challenge because of the lack of long-term tracing and nucleus-specific analyses of newborn neurons in the hypothalamus of patients with Alzheimer's disease. Further research into the molecular mechanisms underlying tanycyte-derived neurogenesis holds promise for identifying small molecules capable of restoring tanycyte proliferation in neurodegenerative diseases. This line of investigation could provide valuable insights into potential therapeu 展开更多
关键词 Alzheimer's disease blood–brain barrier ependymoglial cells HYPOTHALAMUS metabolic diseases neural stem cells NEUROGENESIS neuroinflammatory diseases NEURONS TANYCYTE
Nanoparticles for the treatment of spinal cord injury
14
作者 Qiwei Yang Di Lu +8 位作者 Jiuping Wu Fuming Liang Huayi Wang Junjie Yang Ganggang Zhang Chen Wang Yanlian Yang Ling Zhu Xinzhi Sun 《Neural Regeneration Research》 SCIE CAS 2025年第6期1665-1680,共16页
Spinal cord injuries lead to significant loss of motor, sensory, and autonomic functions, presenting major challenges in neural regeneration. Achieving effective therapeutic concentrations at injury sites has been a s... Spinal cord injuries lead to significant loss of motor, sensory, and autonomic functions, presenting major challenges in neural regeneration. Achieving effective therapeutic concentrations at injury sites has been a slow process, partly due to the difficulty of delivering drugs effectively. Nanoparticles, with their targeted delivery capabilities, biocompatibility, and enhanced bioavailability over conventional drugs, are garnering attention for spinal cord injury treatment. This review explores the current mechanisms and shortcomings of existing treatments, highlighting the benefits and progress of nanoparticle-based approaches. We detail nanoparticle delivery methods for spinal cord injury, including local and intravenous injections, oral delivery, and biomaterial-assisted implantation, alongside strategies such as drug loading and surface modification. The discussion extends to how nanoparticles aid in reducing oxidative stress, dampening inflammation, fostering neural regeneration, and promoting angiogenesis. We summarize the use of various types of nanoparticles for treating spinal cord injuries, including metallic, polymeric, protein-based, inorganic non-metallic, and lipid nanoparticles. We also discuss the challenges faced, such as biosafety, effectiveness in humans, precise dosage control, standardization of production and characterization, immune responses, and targeted delivery in vivo. Additionally, we explore future directions, such as improving biosafety, standardizing manufacturing and characterization processes, and advancing human trials. Nanoparticles have shown considerable progress in targeted delivery and enhancing treatment efficacy for spinal cord injuries, presenting significant potential for clinical use and drug development. 展开更多
关键词 ANTIOXIDANTS axon regeneration biocompatible materials drug carriers NANOPARTICLES nerve regeneration neuroinflammatory diseases NEUROPROTECTION spinal cord injury stem cells
Antidepressant effects of Yuanzhi (Polygalae Radix) extract on chronic unpredictable mild stress-induced depression in rats: modulation of the NLRP3 inflammasome and NF-κB pathway
15
作者 CHEN Yuzhen ZHAO Yongzhi +4 位作者 ZHANG Yiwen CHEN Fang Iqbal Choudhary Muhammad LIU Xinmin JIANG Ning 《Digital Chinese Medicine》 CAS CSCD 2024年第2期184-194,共11页
Objective To investigate the antidepressant effects of Yuanzhi(Polygalae Radix;PR)aqueous extract on chronic unpredictable mild stress(CUMS)-induced depression rat models and the underlying mechanisms.Methods A total ... Objective To investigate the antidepressant effects of Yuanzhi(Polygalae Radix;PR)aqueous extract on chronic unpredictable mild stress(CUMS)-induced depression rat models and the underlying mechanisms.Methods A total of 40 male Sprague Dawley(SD)rats were randomly divided into control;model;low dose of PR(PR-L;0.5 g/kg);high dose of PR(PR-H;1 g/kg);and fluoxetine(10 mg/kg)groups;with 8 rats in each group.Except for the rats in control group;those in the other four groups underwent CUMS-induced depression modeling.PR and fluoxetine were administered intragastrically once daily;30 min prior to the CUMS procedure;for 14 consecu-tive days until the behavioral tests were performed.After CUMS modeling;the sucrose prefer-ence test(SPT);open field test(OFT);novelty-suppressed feeding test(NSFT);forced swim test(FST);and tail suspension test(TST)were employed to assess the pharmacological ef-fects of PR on the mitigation of depressive-like behaviors in rat models.Additionally;the en-zyme-linked immunosorbent assay(ELISA)was utilized to quantify the serum levels of tumor necrosis factor(TNF)-α;interleukin(IL)-6;and IL-1βin the rats.Western blot analysis was al-so conducted to evaluate the protein expression levels of nuclear factor kappa-B(NF-κB);in-ducible nitric oxide synthase(iNOS);cyclooxygenase-2(COX-2);nucleotide-binding oligomerization domain(NOD)-like receptor family pyrin domain containing 3(NLRP3);apoptosis-associated speck-like protein containing caspase recruitment domain(ASC);and caspase-1 in the hippocampal tissues of the rats.Immunofluorescence staining was per-formed to observe the morphological changes in ionized calcium-binding adapter molecule 1 positive(Iba-1+)cells in the dentate gyrus(DG)of rats with CUMS-induced depression.Results(i)Treatment with PR-H and fluoxetine resulted in significant enhancements in both the total distance and time the rats moved during tests(P<0.01 and P<0.05;respectively).Post-administration of PR-H and fluoxetine also led to statistically significant increase in su-crose 展开更多
关键词 DEPRESSION Yuanzhi(Polygalae Radix) Chronic unpredictable mild stress(CUMS) Proinflammatory cytokine neuroinflammatory
下载PDF
The role of axon guidance molecules in the pathogenesis of epilepsy
16
作者 Zheng Liu Chunhua Pan Hao Huang 《Neural Regeneration Research》 SCIE CAS 2025年第5期1244-1257,共14页
Current treatments for epilepsy can only manage the symptoms of the condition but cannot alter the initial onset or halt the progression of the disease. Consequently, it is crucial to identify drugs that can target no... Current treatments for epilepsy can only manage the symptoms of the condition but cannot alter the initial onset or halt the progression of the disease. Consequently, it is crucial to identify drugs that can target novel cellular and molecular mechanisms and mechanisms of action. Increasing evidence suggests that axon guidance molecules play a role in the structural and functional modifications of neural networks and that the dysregulation of these molecules is associated with epilepsy susceptibility. In this review, we discuss the essential role of axon guidance molecules in neuronal activity in patients with epilepsy as well as the impact of these molecules on synaptic plasticity and brain tissue remodeling. Furthermore, we examine the relationship between axon guidance molecules and neuroinflammation, as well as the structural changes in specific brain regions that contribute to the development of epilepsy. Ample evidence indicates that axon guidance molecules, including semaphorins and ephrins, play a fundamental role in guiding axon growth and the establishment of synaptic connections. Deviations in their expression or function can disrupt neuronal connections, ultimately leading to epileptic seizures. The remodeling of neural networks is a significant characteristic of epilepsy, with axon guidance molecules playing a role in the dynamic reorganization of neural circuits. This, in turn, affects synapse formation and elimination. Dysregulation of these molecules can upset the delicate balance between excitation and inhibition within a neural network, thereby increasing the risk of overexcitation and the development of epilepsy. Inflammatory signals can regulate the expression and function of axon guidance molecules, thus influencing axonal growth, axon orientation, and synaptic plasticity. The dysregulation of neuroinflammation can intensify neuronal dysfunction and contribute to the occurrence of epilepsy. This review delves into the mechanisms associated with the pathogenicity of axon guidance molecules in 展开更多
关键词 axon guidance drug-resistant epilepsy EPILEPSY nerve regeneration nervous system diseases neural pathways neuroinflammatory diseases neuronal plasticity NEURONS synaptic remodeling
The complex effects of miR-146a in the pathogenesis of Alzheimer's disease
17
作者 Yunfan Long Jiajia Liu +2 位作者 Yu Wang Haidong Guo Guohong Cui 《Neural Regeneration Research》 SCIE CAS 2025年第5期1309-1323,共15页
Alzheimer's disease is a neurodegenerative disorder characterized by cognitive dysfunction and behavioral abnormalities.Neuroinflammatory plaques formed through the extracellular deposition of amyloid-βproteins,a... Alzheimer's disease is a neurodegenerative disorder characterized by cognitive dysfunction and behavioral abnormalities.Neuroinflammatory plaques formed through the extracellular deposition of amyloid-βproteins,as well as neurofibrillary tangles formed by the intracellular deposition of hyperphosphorylated tau proteins,comprise two typical pathological features of Alzheimer's disease.Besides symptomatic treatment,there are no effective therapies for delaying Alzheimer's disease progression.MicroRNAs(miR)are small,non-coding RNAs that negatively regulate gene expression at the transcriptional and translational levels and play important roles in multiple physiological and pathological processes.Indeed,miR-146a,a NF-κB-regulated gene,has been extensively implicated in the development of Alzheimer's disease through several pathways.Research has demonstrated substantial dysregulation of miR-146a both during the initial phases and throughout the progression of this disorder.Mi R-146a is believed to reduce amyloid-βdeposition and tau protein hyperphosphorylation through the TLR/IRAK1/TRAF6 pathway;however,there is also evidence supporting that it can promote these processes through many other pathways,thus exacerbating the pathological manifestations of Alzheimer's disease.It has been widely reported that miR-146a mediates synaptic dysfunction,mitochondrial dysfunction,and neuronal death by targeting m RNAs encoding synapticrelated proteins,mitochondrial-related proteins,and membrane proteins,as well as other mRNAs.Regarding the impact on glial cells,miR-146a also exhibits differential effects.On one hand,it causes widespread and sustained inflammation through certain pathways,while on the other hand,it can reverse the polarization of astrocytes and microglia,alleviate neuroinflammation,and promote oligodendrocyte progenitor cell differentiation,thus maintaining the normal function of the myelin sheath and exerting a protective effect on neurons.In this review,we provide a comprehensive analysis of the involvement of 展开更多
关键词 Alzheimer's disease amyloid-β glial cells MICRORNAS MIR-146A neuroinflammatory
The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson's disease 被引量:4
18
作者 Jing Wang Xiao-Na Zhang +4 位作者 Jin-Ni Fang Fei-Fei Hua Jing-Yang Han Zeng-Qiang Yuan An-Mu Xie 《Neural Regeneration Research》 SCIE CAS CSCD 2022年第4期898-904,共7页
Previous studies have shown that the ATP-P2 X4 receptor signaling pathway mediates the activation of the Nod-like receptor family protein 3(NLRP3)inflammasome.The NLRP3 inflammasome may promote renal interstitial infl... Previous studies have shown that the ATP-P2 X4 receptor signaling pathway mediates the activation of the Nod-like receptor family protein 3(NLRP3)inflammasome.The NLRP3 inflammasome may promote renal interstitial inflammation in diabetic nephropathy.As inflammation also plays an important role in the pathogenesis of Parkinson's disease,we hypothesized that the ATP-P2 X4 receptor signaling pathway may activate the NLRP3 inflammasome in Parkinson's disease.A male rat model of Parkinson's disease was induced by stereotactic injection of 6-hydroxydopamine into the pars compacta of the substantia nigra.The P2 X4 receptor and the NLRP3 inflammasome(interleukin-1βand interleukin-18)were activated.Intracerebroventricular injection of the selective P2 X4 receptor antagonist 5-(3-bromophenyl)-1,3-dihydro-2 H-benzofuro[3,2-e]-1,4-diazepin-2-one(5-BDBD)or knockdown of P2 X4 receptor expression by si RNA inhibited the activation of the NLRP3 inflammasome and alleviated dopaminergic neurodegeneration and neuroinflammation.Our results suggest that the ATP-P2 X4 receptor signaling pathway mediates NLRP3 inflammasome activation,dopaminergic neurodegeneration,and dopamine levels.These findings reveal a novel role of the ATP-P2 X4 axis in the molecular mechanisms underlying Parkinson's disease,thus providing a new target for treatment.This study was approved by the Animal Ethics Committee of Qingdao University,China,on March 5,2015(approval No.QYFYWZLL 26119). 展开更多
关键词 ATP neurodegenerative disorder NEUROINFLAMMATION neuroinflammatory response NLRP3 P2X4 Parkinson's disease
下载PDF
基于炎症反应探讨益母草对脑缺血再灌注损伤的影响 被引量:1
19
作者 李艳 苗明三 《时珍国医国药》 CAS CSCD 北大核心 2023年第6期1340-1344,共5页
为探索益母草抗脑缺血再灌注损伤神经炎症反应的作用机制。该研究通过提取益母草中的总生物碱,将KM雄性小鼠随机分为假手术组(Sham)、模型组(CIRI)、益母草低剂量组(LHA-L,30mg·kg^(-1))、益母草中剂量组(LHA-M,60mg·kg^(-1)... 为探索益母草抗脑缺血再灌注损伤神经炎症反应的作用机制。该研究通过提取益母草中的总生物碱,将KM雄性小鼠随机分为假手术组(Sham)、模型组(CIRI)、益母草低剂量组(LHA-L,30mg·kg^(-1))、益母草中剂量组(LHA-M,60mg·kg^(-1))、益母草高剂量组(LHA-H,120mg·kg^(-1))。小鼠分组后即灌服相应药物,连续14d,其中Sham和CIRI组给予同体积的生理盐水。第14天给药1h后,对各组小鼠复制反复缺血再灌注损伤模型,再灌注24h,取材。ELISA(en-zyme-linked immunosorbent assay)检测小鼠血清的白细胞介素-6(interleukin-6,IL-6)、IL-1β和肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)水平;HE染色检测脑组织病理变化;尼氏染色法观察脑组织尼氏体的变化;免疫荧光法检测小鼠脑组织中GFAP的表达;RT-PCR法检测脑组织IL-1βmRNA、IL-6 mRNA、TNF-αmRNA、COX-2 mRNA的表达。研究结果表明,反复缺血可致小鼠急性脑缺血再灌注模型制备成功,益母草可降低脑缺血再灌注损伤小鼠血清IL-6、IL-1β和TNF-α水平,下调脑组织中GFAP蛋白表达,改善脑组织病理变化,减低脑组织中IL-1βmRNA、IL-6 mRNA、TNF-αmRNA、COX-2 mRNA的表达。益母草可以通过抑制神经炎症反应,促进细胞修复,从而保护脑缺血再灌注损伤的炎症损伤。 展开更多
关键词 益母草 脑缺血再灌注损伤 神经炎症
原文传递
中药复方CHPⅡ对PDAPP^(V717I)转基因小鼠脑组织病变的影响 被引量:3
20
作者 张建民 胡愉 +3 位作者 王红 孔庆利 刘庆丰 何维 《解剖学报》 CAS CSCD 北大核心 2004年第6期622-625,共4页
目的 研究中药复方 (CHPII)对PDAPPV71 7I转基因小鼠脑组织内病理改变的影响。 方法 通过免疫组织化学染色检测CHPⅡ对PDAPPV71 7I转基因小鼠脑组织内淀粉样蛋白沉淀和反应性星形胶质细胞活化程度的影响。 结果 CHPⅡ治疗组PDAPPV7... 目的 研究中药复方 (CHPII)对PDAPPV71 7I转基因小鼠脑组织内病理改变的影响。 方法 通过免疫组织化学染色检测CHPⅡ对PDAPPV71 7I转基因小鼠脑组织内淀粉样蛋白沉淀和反应性星形胶质细胞活化程度的影响。 结果 CHPⅡ治疗组PDAPPV71 7I转基因小鼠脑组织内淀粉样蛋白沉淀的水平明显低于对照组和脑复康组 ,反应性星形胶质细胞的活化程度也明显降低。 结论 CHPⅡ能够明显降低PDAPPV71 7I转基因小鼠脑组织内淀粉样蛋白沉淀 ,降低脑组织内的神经炎症反应。 展开更多
关键词 阿尔茨海默病 PDAP^V717I转基因小鼠 中药 淀粉样蛋白 神经炎症
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部